Suppression Of Atrial Fibrillation With Ranolazine After Cardiac Surgery

Trial Profile

Suppression Of Atrial Fibrillation With Ranolazine After Cardiac Surgery

Discontinued
Phase of Trial: Phase III

Latest Information Update: 10 Jan 2017

At a glance

  • Drugs Ranolazine (Primary)
  • Indications Atrial fibrillation
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Nov 2016 Status changed from recruiting to discontinued due lack of enrollment.
    • 24 Jul 2012 Primary endpoint amended as reported by ClinicalTrials.gov.
    • 14 May 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top